From Australian Doctor, April 26, 2007:
Questions over the ownership of the H5N1 influenza strain raise wider issues about medical research, individual rights and company profits.
WHEN CSL proudly announced in January that it was applying to register its pandemic influenza vaccine, the company could not have foreseen that its supporting dossier would spark a global storm with far-reaching implications for vaccine research. Read more.
Skip to content
freelance science journalist and author
Bianca Nogrady
%d bloggers like this:
